Top DTC Genetic Testing startups
There are 224 DTC Genetic Testing startups which include 23andMe, MyHeritage, Helix, Color, Nucleus Genomics. Out of these, 68 startups are funded, with 27 having secured Series A+ funding. United States has the most number of companies in DTC Genetic Testing (86), followed by Canada
(17), and then China (14).
Over the past 10 years, an average of 10 new companies have been launched annually. Notably, several of these startups have been founded by alumni of Stanford University, Harvard University and Harvard Business School.
Here is the list of top DTC Genetic Testing Startups
1. 23andMe
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits. The platform provides a study regarding an individual's ancestry, genealogy, and inherited traits. The company also markets its data is categorized and searchable form to researchers and scientists.
Key facts about 23andMe
- Founded Year: 2006
- Location: Sunnyvale (United States)
- Stage: Acquired
- Total Funding till date: $944M
- Investors: Fidelity Investments, Sequoia Capital and 32 Others
- Latest Funding Round: Post IPO, Nov 03, 2023, $*****
- Tracxn Score: 78/100 What is this?
- Competitors Rank: 2 of 63 Competitors
2. MyHeritage
Provider of tools for creating family trees and exploring ancestry. It offers resources for building family trees by adding names, dates, photos, and stories. The platform provides access to historical records to discover information about ancestors. It also offers DNA testing to reveal ethnic backgrounds and connect with relatives.
Key facts about MyHeritage
- Founded Year: 2003
- Location: Yehud (Israel)
- Stage: Acquired
- Total Funding till date: $49M
- Investors: Index Ventures, Bessemer Venture Partners and 10 Others
- Latest Funding Round: Series B, Nov 28, 2012, $*****
- Tracxn Score: 76/100 What is this?
- Competitors Rank: 2 of 12 Competitors
3. Helix
Provider of a genomic database for clinical research. The company has a proprietary clinical-genomic database of Exome+ sequencing data and deep phenotypic data that can be used to accelerate the drug development lifecycle from discovery to commercialization. It offers data analytics platforms for health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making.
Key facts about Helix
- Founded Year: 2015
- Location: San Francisco (United States)
- Stage: Series E
- Total Funding till date: $435M
- Investors: DFJ Growth, Kleiner Perkins and 12 Others
- Latest Funding Round: Series E, Jun 03, 2021, $*****
- Tracxn Score: 71/100 What is this?
- Competitors Rank: 2 of 387 Competitors
4. Color
Provider of end-to-end Virtual clinic offering cancer-based solutions. It assesses cancer risk, increases screening accessibility, and accelerates diagnosis. It guides patients through treatment and provides support for survivors. It offers direct care through an in house care team, including oncologists, primary care physicians, genetic counselors, and oncology-trained care advocates. It integrates with health plans and existing benefits ecosystems.
Key facts about Color
- Founded Year: 2013
- Location: Burlingame (United States)
- Stage: Series E
- Total Funding till date: $491M
- Investors: General Catalyst, T. Rowe Price and 46 Others
- Latest Funding Round: Series E, Oct 26, 2021, $*****
- Tracxn Score: 66/100 What is this?
- Competitors Rank: 18 of 572 Competitors
Provider of genetic testing kits for rare variant analysis. The company offers direct to consumer genetic testing platform that provides genetic risk and disposition score analyses on an extensive number of diseases and traits by leveraging whole-genome sequencing (WGS).
Key facts about Nucleus Genomics
- Founded Year: 2021
- Location: Manhattan (United States)
- Stage: Series A
- Total Funding till date: $32M
- Investors: Founders Fund, Seven Seven Six and 26 Others
- Latest Funding Round: Series A, Jan 30, 2025, $*****
- Tracxn Score: 60/100 What is this?
- Competitors Rank: 4 of 60 Competitors
